共 126 条
[1]
Fujita S(2017)Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled noninferiority trial Ann Surg 266 201-207
[2]
Mizusawa J(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740
[3]
Kanemitsu Y(2012)Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer J Clin Oncol 30 4558-4565
[4]
Ito M(2015)Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial Ann Oncol 26 1722-1728
[5]
Kinugasa Y(2019)Long-course preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study Ann Oncol 30 1298-1303
[6]
Komori K(2016)Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis Lancet Oncol 17 174-183
[7]
Ohue M(2019)Assessment of the value of comorbidity indices for risk adjustment in colorectal surgery patients Ann Surg Oncol 26 2797-2804
[8]
Ota M(2017)Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 28 22-40
[9]
Akazai Y(2009)Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) Radiother Oncol 92 148-163
[10]
Shiozawa M(2005)The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus Radiother Oncol 76 241-250